Fox Chase Cancer Center Receives NIH Grant for Multiphoton Microscopy System

Tim J. Yen, PhD
Tim J. Yen, PhD

PHILADELPHIA (November 21, 2018) – The National Institutes of Health has awarded a $599,789 grant to Fox Chase Cancer Center for the purchase of a multiphoton microscopy system. The purchase and management of the equipment will be conducted by Tim J. Yen, PhD, director of the Biological Imaging Facility at Fox Chase.  

“Biological imaging is a vital technology in modern cancer and cell biological, research and remains an essential component of all research programs at Fox Chase Cancer Center,” Yen said.

Under the terms of the grant, the equipment will be shared across 52 investigators in multiple labs. The core mission of the facility is to provide cost-effective access to state of the art equipment and technologies to its research base. Users will have access to a full range of light and electron microscopy equipment and various small animal imaging modalities.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text